Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
COPD: early diagnosis and treatment to slow disease progression
by
Welte, T.
, Vogelmeier, C.
, Papi, A.
in
Asymptomatic
/ Bronchodilators
/ Chronic obstructive pulmonary disease
/ Cigarette smoking
/ Clinical trials
/ Corticosteroids
/ Disease Management
/ Disease Progression
/ Drug addiction
/ Drug therapy
/ Early Diagnosis
/ Exercise
/ Health care expenditures
/ Humans
/ Lung diseases
/ Mortality
/ Patients
/ Physical fitness
/ Pulmonary Disease, Chronic Obstructive - diagnosis
/ Pulmonary Disease, Chronic Obstructive - therapy
/ Quality of life
/ Respiratory function
/ Spirometry
2015
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
COPD: early diagnosis and treatment to slow disease progression
by
Welte, T.
, Vogelmeier, C.
, Papi, A.
in
Asymptomatic
/ Bronchodilators
/ Chronic obstructive pulmonary disease
/ Cigarette smoking
/ Clinical trials
/ Corticosteroids
/ Disease Management
/ Disease Progression
/ Drug addiction
/ Drug therapy
/ Early Diagnosis
/ Exercise
/ Health care expenditures
/ Humans
/ Lung diseases
/ Mortality
/ Patients
/ Physical fitness
/ Pulmonary Disease, Chronic Obstructive - diagnosis
/ Pulmonary Disease, Chronic Obstructive - therapy
/ Quality of life
/ Respiratory function
/ Spirometry
2015
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
COPD: early diagnosis and treatment to slow disease progression
by
Welte, T.
, Vogelmeier, C.
, Papi, A.
in
Asymptomatic
/ Bronchodilators
/ Chronic obstructive pulmonary disease
/ Cigarette smoking
/ Clinical trials
/ Corticosteroids
/ Disease Management
/ Disease Progression
/ Drug addiction
/ Drug therapy
/ Early Diagnosis
/ Exercise
/ Health care expenditures
/ Humans
/ Lung diseases
/ Mortality
/ Patients
/ Physical fitness
/ Pulmonary Disease, Chronic Obstructive - diagnosis
/ Pulmonary Disease, Chronic Obstructive - therapy
/ Quality of life
/ Respiratory function
/ Spirometry
2015
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
COPD: early diagnosis and treatment to slow disease progression
Journal Article
COPD: early diagnosis and treatment to slow disease progression
2015
Request Book From Autostore
and Choose the Collection Method
Overview
Summary Aims Chronic obstructive pulmonary disease (COPD) is usually a progressive condition. Undiagnosed early‐stage disease, particularly in symptomatic patients, is likely to become more severe with time. Hence, prevention or reduction in disease progression is highly relevant. We evaluated the published data and discussed the potential impact of early intervention on the course of COPD. Methods We performed PubMed searches of studies in early or mild COPD, focusing on those relating to lung function decline. Results Smoking cessation reduced lung function decline at all stages of COPD, and the earlier the intervention, the greater the impact on lung function. Accumulating data from placebo‐controlled trials suggested that long‐acting bronchodilators can slow the decline in lung function, as well as reduce exacerbation and mortality rates and improve health‐related quality of life (HRQoL) in patients with mild‐to‐moderate COPD. Inhaled corticosteroids (ICS) do not impact lung function in early COPD, and further research is needed on the role of long‐acting β2‐agonist‐ICS combination therapy in these patients. Conclusions Initiating treatment early in the course of COPD is likely to slow disease progression and improve HRQoL. Current data support maintenance treatment with a long‐acting bronchodilator in this patient group. However, many questions remain unanswered regarding the optimal treatment of mild COPD, and further research is required to develop evidence‐based recommendations in this field.
Publisher
Blackwell Publishing Ltd,John Wiley & Sons, Inc
MBRLCatalogueRelatedBooks
Related Items
Related Items
We currently cannot retrieve any items related to this title. Kindly check back at a later time.
This website uses cookies to ensure you get the best experience on our website.